Key statistics dashboard for NeuroOne Medical Technologies Corporation (NMTC). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems.
Stock Data
| Price | $1.41 |
| Market Cap | $12M |
| Enterprise Value | $10.3M |
| Beta | 0.58 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -1.54 |
| Price / Book | 3.24 |
| P/S | 1.23 |
| EV/EBITDA | -1.49 |
| EV/Sales | 1.03 |
| EV/FCF | -1.44 |
| P/FCF | -1.71 |
| Earnings Yield | -58.54% |
| FCF Yield | -58.36% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 55.67% |
| EBIT Margin | -71.51% |
| EBITDA Margin | -69.14% |
| Operating Margin | -76.05% |
| Net Margin | -71.51% |
| Return on Equity | -126.45% |
| Return on Assets | -115.57% |
| Return on Invested Capital | -183.45% |
| Return on Capital Employed | -183.45% |
Financial Health
| Current Ratio | 2.84 |
| Quick Ratio | 1.71 |
| Cash Ratio | 1.00 |
| Debt / Equity | 0.02 |
| Debt / Assets | 1.19% |
| Net Debt / EBITDA | 0.29 |
| Interest Coverage | 22.76 |
Per-Share Data
| Revenue per share | 1.15 |
| Book Value per share | 0.43 |
| Cash per share | 0.24 |
| FCF per share | -0.83 |
| Tangible Book Value per share | 0.43 |
| Dividend per share | 0.00 |
Related companies: ATHE · BDMD · CTSO · ECOR · HYPD · MYO · RBOT
Explore sector: Healthcare · Medical - Devices
More sections of NMTC: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks